Tysabri - New Drug for MS

home   >   feedster

MS Drug Gets Quick FDA Approval One-Year Results Prompt Agency to Expedite Tysabri, From Biogen Idec, Elan By DAVID ARMSTRONG Staff Reporter of THE WALL STREET JOURNAL November 24, 2004 The Food and Drug Administration granted expedited approval to a drug for multiple sclerosis that has produced impressive results in clinical trials. The drug from Biogen Idec Inc. and Elan

- link to Tysabri - New Drug for MS -
Last update: 06/01/2005

Recommended Reading

    Se viene el invierno y la gripe.(cuidado y tratamiento)(TT: Winter and the common cold are approaching.)(TA: care and treatment) : An article from: Semana
    Fever Of War: The Influenza Epidemic In The U.s. Army During World War I
    CDC advisory panel: flu vaccine deemed safe in pregnancy.(Infectious Diseases)(Centers for Disease Control ) : An article from: Internal Medicine News
    Push to vaccinate health workers: coalition battles influenza. : An article from: Family Practice News
    Gel makers hit on SOPs, process validation errors.(Sombra Cosmetics)(Brief Article) : An article from: Validation Times
    America's Forgotten Pandemic : The Influenza of 1918
    Divining Women (Unabridged)
    Abortion in America: The Origins and Evolution of National Policy, 1800-1900 (Galaxy Books)